SOBR Safe (NASDAQ:SOBR) Upgraded to “Sell” at Wall Street Zen

Wall Street Zen upgraded shares of SOBR Safe (NASDAQ:SOBRFree Report) to a sell rating in a report published on Saturday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of SOBR Safe in a research report on Wednesday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Get Our Latest Research Report on SOBR Safe

SOBR Safe Price Performance

Shares of NASDAQ SOBR opened at $0.53 on Friday. SOBR Safe has a fifty-two week low of $0.35 and a fifty-two week high of $4.00. The firm has a market capitalization of $1.49 million, a P/E ratio of -0.09 and a beta of 1.20. The company’s 50 day simple moving average is $0.88 and its 200 day simple moving average is $0.95.

SOBR Safe (NASDAQ:SOBRGet Free Report) last released its earnings results on Thursday, April 30th. The company reported ($0.82) EPS for the quarter. The business had revenue of $0.08 million for the quarter. SOBR Safe had a negative return on equity of 172.71% and a negative net margin of 2,166.28%.

Institutional Investors Weigh In On SOBR Safe

An institutional investor recently bought a new stake in SOBR Safe stock. Citadel Advisors LLC purchased a new position in shares of SOBR Safe, Inc. (NASDAQ:SOBRFree Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 19,272 shares of the company’s stock, valued at approximately $67,000. Citadel Advisors LLC owned approximately 1.27% of SOBR Safe as of its most recent SEC filing. Institutional investors own 7.93% of the company’s stock.

About SOBR Safe

(Get Free Report)

SOBR Safe, Inc (NASDAQ: SOBR) is a technology company specializing in the development and commercialization of cognitive impairment monitoring solutions. The company’s flagship offerings consist of handheld breath alcohol screening devices and integrated cognitive assessment tools designed to detect impairment in real time. SOBR Safe’s product line pairs portable breathalyzers with proprietary software that captures, records and analyzes impairment data to help organizations maintain safety and compliance standards.

Founded in 2020 and headquartered in Vancouver, Canada, SOBR Safe has focused on research and development of non-invasive impairment detection technology.

Further Reading

Receive News & Ratings for SOBR Safe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOBR Safe and related companies with MarketBeat.com's FREE daily email newsletter.